
İstanbul Transcatheter Therapeutics Course (ITT) 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to İstanbul Transcatheter Therapeutics Course (ITT) 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
İstanbul Transcatheter Therapeutics Course (ITT 2026)
Event type: Medical education, interventional cardiology, structural heart, transcatheter therapies, clinical training, expert lectures, hands-on learning
Likely audience: Cardiologists, interventional cardiologists, cardiac surgeons, cath lab specialists, nurses, fellows, hospital administrators, medical device companies, clinical education teams, and healthcare procurement stakeholders
Estimated attendance: Medium-size specialized medical audience, likely in the range of 300 to 1,000+ delegates depending on final agenda, faculty, and sponsor participation
Event overview
İstanbul Transcatheter Therapeutics Course (ITT 2026) is a highly specialized cardiovascular education event focused on transcatheter and minimally invasive therapeutic techniques. This type of conference usually attracts a concentrated mix of clinical decision-makers, procedure-focused physicians, device manufacturers, and hospital-based specialists who are actively involved in adopting, evaluating, recommending, or using advanced treatment technologies.
For attendee-list and buyer-intelligence purposes, this is a premium medical event because the audience is not broad and generic. It is tightly aligned with high-value healthcare professionals and commercial buyers in the cardiology and medical device ecosystem. The strongest buyers are usually medical technology companies, hospital networks, training providers, imaging solution vendors, catheter and implant manufacturers, simulation companies, and clinical education organizations.
1️⃣ Who attends: Buyers / attendees
The core attendees are likely to be medical professionals and industry stakeholders connected to interventional cardiology and structural heart therapy. This is not a consumer event. It is a specialty B2B healthcare education environment where the real buyer value sits in clinical influence, purchasing authority, product evaluation, and procedure adoption.
Main attendee groups:
- Interventional cardiologists
- General cardiologists with interest in transcatheter therapies
- Cardiac surgeons
- Structural heart specialists
- Cath lab directors and cath lab managers
- Fellows, residents, and advanced trainees in cardiology
- Hospital procurement and clinical purchasing teams
- Medical device sales and clinical specialist teams
- Product managers and market development teams from cardiovascular companies
- Training and education managers from healthcare technology firms
- Nurses and technologists working in interventional care units
- Academic faculty, researchers, and opinion leaders
From a buyer-list perspective, the most valuable attendees are the clinicians and department leaders who influence vendor selection, device adoption, clinical protocols, and training requirements. In many cases, they are not the final purchasing signers, but they are very important influencers in the buying process.
2️⃣ Where the show is happening + attendee geographic origin
Location: İstanbul, Turkey. The event name strongly suggests a major metropolitan medical meeting held in Istanbul, which is a strategic hub for regional and international healthcare events.
Attendee geographic origin: Most likely a mix of Turkey-based specialists plus regional and international medical professionals from Europe, the Middle East, Central Asia, and nearby global markets. Istanbul is well positioned to draw visitors from both domestic and cross-border medical communities.
Best geographic targeting:
- Turkey nationwide, especially major hospital cities
- Regional attendees from Europe, Middle East, North Africa, and Central Asia
- International faculty, sponsors, and device-company delegates
- Large metropolitan hospitals, private healthcare chains, teaching hospitals, and academic medical centers
3️⃣ Audience reach
Reach type: Regional with international specialty reach
This event is likely strongest in the regional healthcare ecosystem rather than being a mass global congress. However, because interventional cardiology is a high-end specialty, the conference may attract international speakers, device sponsors, and expert clinicians from outside Turkey.
For database value, the audience is excellent because it is highly qualified and tightly aligned with high-value medical purchasing and clinical influence.
4️⃣ Sample buyer company names + websites
Below is a sample buyer table with organizations that are likely to be relevant buyers, sponsors, exhibitors, or high-value commercial targets for this event. These are selected based on transcatheter therapy, cardiovascular devices, imaging, hospital technology, and clinical education relevance.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Edwards Lifesciences | edwards.com | Clinical Education Manager / Territory Manager / Market Development Manager | Strong fit for structural heart, transcatheter valve therapies, physician education, and hospital engagement. |
| 2 | Medtronic | medtronic.com | Medical Education Manager / Regional Sales Director / Clinical Specialist | Major cardiovascular and transcatheter device company with direct relevance to specialty cardiology events. |
| 3 | Abbott | abbott.com | Structural Heart Sales Manager / Medical Affairs Manager / Product Manager | Relevant across cardiovascular devices, diagnostic support, and hospital-based product adoption. |
| 4 | Boston Scientific | bostonscientific.com | Interventional Cardiology Marketing Manager / Clinical Specialist / Sales Director | Very strong match for interventional cardiology, catheter-based therapies, and physician engagement. |
| 5 | Philips | philips.com | Clinical Sales Manager / Imaging Solutions Manager / Medical Affairs Lead | Excellent fit for imaging, guidance systems, cath lab technology, and clinical workflow support. |
| 6 | GE HealthCare | gehealthcare.com | Cardiology Product Manager / Clinical Application Specialist / Account Executive | Relevant for imaging, diagnostics, cath lab systems, and hospital decision-makers. |
| 7 | Siemens Healthineers | siemens-healthineers.com | Regional Sales Manager / Clinical Marketing Manager / Interventional Imaging Lead | Strong fit for imaging, interventional suite technology, and advanced clinical workflows. |
| 8 | Terumo | terumo.com | Business Development Manager / Medical Education Specialist / Territory Manager | Well aligned with vascular access, catheter technologies, and interventional procedure support. |
| 9 | B. Braun | bbraun.com | Hospital Sales Manager / Clinical Education Specialist / Product Manager | Good fit for hospital devices, infusion-related systems, and clinical training stakeholders. |
| 10 | Meril Life Sciences | merillife.com | International Sales Manager / Medical Education Lead / Structural Heart Specialist | Strong cardiovascular and transcatheter therapy relevance, especially in emerging and regional markets. |
| 11 | MicroPort | microport.com | Product Marketing Manager / Country Manager / Clinical Affairs Manager | Good fit for advanced medical devices and regional cardiology market development. |
| 12 | Konica Minolta Healthcare | konicaminolta.com | Healthcare Solutions Manager / Sales Director / Product Specialist | Relevant where imaging, workflow, and hospital diagnostic technology intersect with specialty care. |
| 13 | Getinge | getinge.com | Cardiovascular Solutions Manager / Sales Manager / Clinical Specialist | Strong hospital and operating-room relevance, especially for procedural and critical care environments. |
| 14 | Cardinal Health | cardinalhealth.com | Hospital Account Manager / Clinical Supply Chain Manager / Product Manager | Relevant if the buyer profile includes procurement, clinical supply, and hospital distribution. |
| 15 | Janssen / Johnson & Johnson MedTech | jnj.com | Medical Affairs Manager / Marketing Manager / Clinical Education Lead | Good fit for device and clinical education strategies in advanced healthcare environments. |
| 16 | Asahi Intecc | asahiintecc.com | Sales Manager / Clinical Specialist / Product Lead | Highly relevant for guidewires and catheter-based interventional products. |
| 17 | Shockwave Medical | shockwavemedical.com | Area Sales Manager / Clinical Specialist / Market Development Manager | Excellent fit for advanced cardiovascular procedures and physician adoption. |
| 18 | Alvimedica | alvimedica.com | International Business Development Manager / Product Manager / Medical Education Manager | Turkey-linked medical device relevance makes this especially meaningful for regional targeting. |
| 19 | Boston Scientific Turkey | bostonscientific.com | Country Manager / Clinical Specialist / Market Access Manager | Useful for local commercial activity, physician engagement, and hospital relationship building. |
| 20 | Philips Türkiye | philips.com | Sales Manager / Clinical Application Lead / Strategic Account Manager | Strong local market relevance for healthcare imaging and interventional technology. |
Top 5 best buyer samples to send first: Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Philips. These are the strongest cross-section of structural heart, interventional cardiology, imaging, and clinical education buyers.
5️⃣ Job profiles, industries & event type
Because this is a specialty cardiovascular course, the best target roles are a mix of clinical decision-makers and commercial healthcare buyers. The event is valuable not only for physicians, but also for device companies and hospital procurement teams that influence product selection and training.
Best job profiles to target:
- Interventional Cardiologist
- Cardiologist
- Cardiac Surgeon
- Structural Heart Specialist
- Cath Lab Director
- Cath Lab Manager
- Medical Affairs Manager
- Clinical Education Manager
- Clinical Specialist
- Regional Sales Manager, Medical Devices
- Product Manager, Cardiovascular
- Market Development Manager
- Hospital Procurement Manager
- Health System Account Manager
- Training and Education Lead
- Medical Science Liaison
- Business Development Manager, Healthcare
- Director of Clinical Operations
Best industries to use:
- Hospital & Health Care
- Medical Devices
- Pharmaceuticals
- Biotechnology
- Research
- Health, Wellness & Fitness
- Information Technology & Services
- Management Consulting
- Professional Training & Coaching
- Market Research
This is primarily a healthcare education and medical technology event. If the goal is attendee-list monetization, the most commercially valuable segment is the device and hospital ecosystem around the doctors, not only the doctors themselves.
6️⃣ Estimated attendance / expected footfall
Estimated total attendance: Likely 300 to 1,000+ depending on the final scope of the course, faculty profile, and sponsor base.
A course format like this typically attracts a smaller but more qualified audience than a broad international congress. The footfall may not be massive, but the lead quality is usually significantly higher because attendees are specialists with strong clinical relevance.
For attendee-list selling, even a few hundred high-quality records can be very valuable if the list includes interventional cardiologists, cath lab leaders, hospital decision-makers, and medical device contacts.
7️⃣ Key focus areas & buyer engagement
Key focus areas:
- Transcatheter cardiovascular therapies
- Structural heart interventions
- Minimally invasive treatment approaches
- Clinical case discussions and live learning
- Catheter-based procedure techniques
- Imaging, guidance, and procedural planning
- Device selection and procedural optimization
- Hospital workflow and cath lab efficiency
- Clinical training and physician education
- Product demonstration and sponsor engagement
Buyer engagement angle:
The best outreach message should not be generic. It should position the audience as a high-value cardiology and interventional healthcare buyer set. A strong message would be:
“We can help you reach interventional cardiologists, structural heart specialists, cath lab leaders, hospital procurement teams, and cardiovascular device companies participating in İstanbul Transcatheter Therapeutics Course 2026.”
That framing is much stronger than simply saying “medical conference attendees,” because it speaks directly to purchasing power, clinical influence, and product adoption.
8️⃣ Client product fit note
Please share your client website before finalizing the exact buyer list. The best buyers depend heavily on what your client sells.
- If your client sells medical devices, focus on interventional cardiology teams, catheter lab leaders, structural heart specialists, and hospital procurement managers.
- If your client sells clinical software or hospital technology, focus on hospital administrators, imaging specialists, cath lab directors, and digital health buyers.
- If your client sells training or education services, target medical education managers, clinical affairs teams, academic hospitals, and faculty organizers.
- If your client sells disposable medical supplies or procedure accessories, target purchasing managers, supply chain teams, and interventional departments.
- If your client sells diagnostic or imaging solutions, target cardiology departments, radiology-adjacent teams, and procedure workflow leaders.
Once you share the client website, I can narrow this down to the most likely buyers by product fit, budget authority, and event relevance.
9️⃣ Industry suggestions based on the industry list
For this event, the most relevant industry filters are the healthcare and medical technology categories. Since the audience is highly specialized, you should prioritize industries that reflect the people buying, influencing, or supporting transcatheter therapy adoption.
Best matching industries from your list:
- Hospital & Health Care
- Medical Devices
- Biotechnology
- Pharmaceuticals
- Research
- Health, Wellness & Fitness
- Information Technology & Services
- Market Research
- Professional Training & Coaching
- Management Consulting
- Medical Practice
- Higher Education
- Education Management
If you want to expand beyond direct healthcare, you can also include:
- Insurance, for health coverage and healthcare analytics buyers
- Financial Services, for healthcare investment and medtech funding contacts
- Venture Capital & Private Equity, for medtech investors
- Public Policy, for health system and regulatory stakeholders
Final recommendation
İstanbul Transcatheter Therapeutics Course (ITT 2026) is a strong specialty event for attendee-list sales if your client targets the medical device, cardiology, hospital technology, or healthcare education market. It is not a broad event, but it is highly focused and commercially useful because the audience contains expert clinicians, clinical influencers, and healthcare buyers.
Quality rating for B2B attendee-list sales: 8.5/10
Why this scores well: the audience is specialized, the buying environment is high-value, and the event likely includes both clinical users and vendor-facing commercial stakeholders. The main limitation is that the audience size may be moderate rather than large, so the best monetization strategy is precision targeting rather than volume selling.
Please share your client website, and I will refine the best buyer segments, best job titles, and the most relevant companies for this exact event.
Data sheet
| Event Name | İstanbul Transcatheter Therapeutics Course (ITT) 2026 |
| Event Date | 12 Jun 2026 - 13 Jun 2026 |
| Event Status | Upcoming |
| Venue | Istanbul (specific venue not publicly confirmed in the supplied brief) |
| City | Istanbul |
| State / Region | Istanbul |
| Country | Türkiye |
| Organizer | Organizer not publicly confirmed in the supplied brief |
| Official Event Website | Not publicly verified in the supplied brief |
| Event Type | Medical education, interventional cardiology, structural heart, transcatheter therapies, clinical training, expert lectures, and hands-on learning |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Likely national with regional international appeal across Türkiye, nearby EMEA cardiology markets, and selected global medical technology stakeholders |
| Estimated Attendance / Expected Footfall | Estimated medium-size specialized audience, likely 300 to 1,000+ delegates |
| Attendance Data Reliability | Estimated. Attendance figure not publicly confirmed by the organizer. |
| Main Purpose of Event | To convene clinical decision-makers, interventional specialists, cardiac care teams, and device ecosystem participants around transcatheter therapeutics, procedural education, treatment innovation, and related procurement and partnership opportunities. |
İstanbul Transcatheter Therapeutics Course (ITT) 2026 appears to be a focused cardiovascular education and procedural-learning event centered on transcatheter and minimally invasive therapeutic approaches. Based on the supplied event description, the course is likely to attract a high-value concentration of interventional cardiologists, cardiac surgeons, cath lab teams, fellows, nurses, hospital stakeholders, and medical device organizations involved in structural heart and catheter-based interventions.
From a commercial and attendee-intelligence perspective, this is a strong specialist event rather than a broad healthcare expo. That generally improves lead quality because attendees are more likely to be directly involved in clinical evaluation, technology adoption, procedural training, capital equipment review, device selection influence, and hospital-side purchasing workflows. For lead generation, the event is particularly relevant to companies serving cardiology, cath lab operations, imaging, procedural support, clinical training, and hospital procurement ecosystems.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Interventional cardiologists | University hospitals, private hospitals, cardiac centers | Strong clinical influence on device selection, procedural protocols, and vendor evaluation | Core audience for structural heart, catheters, implants, imaging, and training solutions |
| Cardiac surgeons | Surgical departments, heart centers, teaching hospitals | Shared influence on treatment pathways and hybrid procedure adoption | Relevant for devices, operating-room integration, and heart-team collaboration offerings |
| Cath lab leaders and specialists | Cath labs, interventional cardiology units, procedural centers | Influence consumables, workflow systems, and operational purchasing recommendations | High relevance for disposables, imaging accessories, monitoring, and lab efficiency tools |
| Hospital procurement and sourcing teams | Public hospitals, private hospital groups, specialty clinics | Commercial and tender-side decision support for approved technologies and suppliers | Critical for contract conversion, tender qualification, and approved vendor onboarding |
| Hospital administrators and service-line directors | Hospital groups, cardiovascular centers, academic medical institutions | Budget influence, strategic adoption, ROI review, and departmental investment decisions | Important for higher-ticket devices, capital equipment, and program expansion solutions |
| Clinical education teams | Medtech companies, hospital education departments, training providers | Support product adoption, user competency, and procedure rollout | Relevant for simulation, continuing education, and proctorship support |
| Medical device companies | Cardiovascular device manufacturers, distributors, imaging vendors | Partnership, channel, and product positioning influence rather than end-user procurement | Useful for partnerships, distribution expansion, and co-marketing discussions |
| Fellows and physician trainees | Teaching hospitals, universities, fellowship programs | Lower immediate buying power but strong long-term influence and product familiarity value | Relevant for education-oriented outreach and future adopter nurturing |
| Nurses and procedural support staff | Cath labs, cardiovascular units, hospitals | Workflow influence, product usability feedback, and day-to-day operational input | Useful for procedural consumables, training, and patient support tools |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Istanbul | Hospital networks, university medical centers, private cardiac practices, distributors | Very High | Primary concentration of clinical and administrative stakeholders due to host-city access and healthcare density |
| Wider Istanbul Region | Regional hospitals, specialty centers, healthcare distributors | High | Likely strong draw for same-day or short-stay professional attendance |
| Türkiye national market | Public and private hospitals, university faculty, procurement stakeholders, fellows | High | Likely national reach because of the specialist nature of the subject matter |
| Nearby regional markets | Selected attendees from Eastern Europe, Balkans, Middle East, and broader EMEA | Medium | Likely where international faculty, medtech partners, or regional clinicians participate |
| Global medtech ecosystem | Clinical education teams, strategic partnerships, regional business leaders | Medium | More likely on sponsor, speaker, or advanced training side than broad delegate volume |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | The event is likely to attract attendees from across Türkiye because its topic is highly specialized and suited to concentrated clinical education audiences. |
| Regional International | Secondary reach | There is likely additional participation from nearby EMEA markets where structural heart and interventional cardiology communities intersect with Istanbul-based medical education. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer company list not publicly verified | N/A | No official 2026 attendee, sponsor, speaker organization, exhibitor, or hospital participation list was provided in the supplied brief. | N/A | Interventional Cardiology Director; Cath Lab Manager; Procurement Manager; Cardiac Service Line Director | Attendance Not Publicly Verified |
| Recommended next-step data source | Official event materials | The highest-value buyer list would come from the official agenda, faculty roster, sponsor page, hospital affiliations, or registration prospectus once published. | N/A | Faculty-affiliated physicians; Procurement heads; Clinical education managers | Confirmed Methodology Guidance |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Director of Interventional Cardiology | Clinical / Cardiology | Director | High clinical authority over procedural adoption and technology evaluation |
| 2 | Interventional Cardiologist | Clinical / Cardiology | Manager to Director-equivalent clinical influence | Primary user and evaluator of transcatheter devices and related tools |
| 3 | Cardiac Surgeon | Surgery / Cardiovascular | Senior Clinical | Important in heart-team decisions, hybrid interventions, and patient pathway design |
| 4 | Cath Lab Manager | Operations / Cath Lab | Manager | Influences consumables, workflow, scheduling, and operational purchasing |
| 5 | Procurement Manager | Procurement / Supply Chain | Manager | Critical for approved supplier onboarding, pricing, and contracting |
| 6 | Strategic Sourcing Manager | Procurement / Supply Chain | Manager | Relevant for category rationalization and vendor selection in hospital groups |
| 7 | Hospital Administrator | Administration | Director to VP | Budget, program growth, and service-line investment influence |
| 8 | Clinical Education Manager | Clinical Education / Training | Manager to Director | Important for adoption programs, training pathways, and education partnerships |
| 9 | Supply Chain Director | Supply Chain | Director | Relevant for multisite procurement standardization and inventory efficiency |
| 10 | Service Line Director, Cardiovascular | Clinical Operations | Director | Connects clinical outcomes, procedure volume, budgeting, and growth strategy |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Primary end-user environment for cardiology procedures and procurement | Hospital systems, specialty centers, heart institutes |
| 2 | Medical Devices | Core supplier and partnership category around transcatheter technologies | Device makers, accessory vendors, structural heart technology suppliers |
| 3 | Biotechnology | Relevant where advanced therapies, biomaterials, or translational cardiovascular innovation are present | Innovation partnerships and clinical research positioning |
| 4 | Pharmaceuticals | Relevant for cardiovascular therapy support and education sponsorship ecosystems | Clinical education, therapy support, and strategic partnerships |
| 5 | Higher Education | University hospitals and academic training programs often drive participation | Faculty outreach, fellowship engagement, collaborative education |
| 6 | Research | Research-active institutions influence adoption of advanced therapeutic approaches | Clinical studies, investigator networks, evidence-generation partnerships |
| 7 | Information Technology & Services | Relevant for digital workflow, imaging integration, and data support in procedural environments | Clinical software, interoperability, workflow analytics |
| 8 | Professional Training & Coaching | Applies to procedural training, simulation, and continuing medical education providers | Hands-on training and physician education programs |
| 9 | Import & Export | Relevant where device distributors and international supply channels support local market access | Distributor and channel development targeting |
| 10 | Wholesale | Useful for regional device and healthcare supply distributors | Distributor-side outreach and channel qualification |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 300 to 1,000+ | Estimated | Supplied event description and specialist-course format | Attendance figure not publicly confirmed by the organizer. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No official exhibitor prospectus supplied | Likely sponsor-led rather than large expo-floor volume |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer registration data supplied | Buyer influence is likely concentrated in hospital and physician segments rather than a formal hosted-buyer program |
| Speaker count | Not publicly confirmed | Unconfirmed | No official faculty roster supplied | Faculty affiliations would materially improve buyer targeting once available |
| Sponsor count | Not publicly confirmed | Unconfirmed | No official sponsor list supplied | Likely useful signal for identifying medtech ecosystem participation |
| Historical attendance | Not available in supplied materials | Historical data unavailable | No prior-year official data supplied | Prior-year evidence would strengthen forecast accuracy |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Transcatheter therapies | Better procedural outcomes, lower invasiveness, therapy expansion | Clinical demonstrations, physician education, evaluation discussions | Catheters, valves, closure devices, delivery systems |
| Structural heart interventions | Advanced treatment pathways and procedure planning support | Heart-team engagement and KOL-led product positioning | Structural heart technologies, imaging solutions, case planning tools |
| Cath lab workflow | Efficiency, throughput, safety, and consumable optimization | Operational ROI conversations with lab leaders and administrators | Workflow software, monitoring, inventory, procedural accessories |
| Clinical education | Training, competency development, implementation support | Workshop sponsorship, simulation, proctorship partnerships | Training platforms, CME support, simulation solutions |
| Imaging and procedure guidance | Better visualization, planning accuracy, and intraprocedural support | Clinical proof-point discussions with physicians and lab teams | Imaging platforms, ultrasound, navigation, data integration |
| Hospital procurement | Cost control, approved vendor selection, tender readiness | Commercial follow-up after clinical validation conversations | Contracting support, value dossiers, supplier onboarding packages |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Audience is likely concentrated around high-value clinical and hospital stakeholders in cardiovascular care. |
| Decision-maker availability | High | Specialist courses typically attract direct users and influential clinical decision-makers. |
| Data collection potential | Medium | Good potential if faculty, sponsors, and agenda affiliations are published; currently limited by lack of official participant materials. |
| Apollo targeting potential | High | Strong alignment with hospital, medical device, education, and research-oriented account targeting. |
| Geographic targeting potential | High | Clear initial targeting cluster in Istanbul and broader Türkiye, with optional EMEA expansion. |
| Best outreach approach | High | Use clinically relevant messaging, procedure-outcome language, and hospital value-case outreach rather than generic event sales copy. |
| Overall lead quality | High | Narrow, specialist medical focus generally improves signal quality versus broad healthcare exhibitions. |
| Best use case | High | Best for medtech outreach, KOL mapping, hospital buyer profiling, and cardiology service-line targeting. |
| Limitations / risks | Medium | Current-year official participant evidence is not yet verified in the supplied materials, limiting confirmed attendee-list building. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Biotechnology; Pharmaceuticals; Higher Education; Research; Information Technology & Services; Professional Training & Coaching; Import & Export; Wholesale | Build a targeted universe of hospital operators, medtech vendors, academic centers, and distributor-side accounts |
| Departments | Clinical; Operations; Procurement; Supply Chain; Education; Administration; Business Development | Focus on the departments most likely to influence adoption or purchasing |
| Seniority | Manager; Director; VP; CXO; Partner; Owner where distributor-side accounts apply | Prioritize decision-makers and high-influence evaluators |
| Job titles | Director of Interventional Cardiology; Interventional Cardiologist; Cardiac Surgeon; Cath Lab Manager; Procurement Manager; Strategic Sourcing Manager; Supply Chain Director; Hospital Administrator; Clinical Education Manager; Cardiovascular Service Line Director | Reach both clinical champions and commercial approvers |
| Geography | Istanbul first; then Türkiye national; then selected EMEA markets if cross-border strategy applies | Aligns with likely attendee concentration and practical event-follow-up radius |
| Employee size | 51-200; 201-500; 501-1000; 1001-5000; 5001+ | Capture specialty clinics, private hospitals, university hospitals, and large health systems |
| Keywords | interventional cardiology; structural heart; transcatheter; cath lab; cardiovascular center; minimally invasive; TAVI; TAVR; valve therapy; endovascular; clinical education | Improve precision for specialist cardiology account discovery |
| Technologies | Use only if relevant to client offer: imaging platforms, hospital information systems, clinical workflow tools | Helpful for digital-health, software, and interoperability-led outreach |
| Revenue range | Prefer mid-market to enterprise hospital systems and established medtech firms where available | Improves commercial qualification for premium medical offerings |
| Company type | Hospitals; University medical centers; Private healthcare groups; Medical device manufacturers; Authorized distributors | Builds a balanced list of clinical end users and commercial channel partners |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Requester-supplied event brief | User-provided event data | Event name, city, region, country, date range, and baseline description of audience and format | Medium |
| Official organizer / event website | Primary source | Not provided in the request and not verified in this report | Pending verification |
| Official agenda / faculty / sponsor / exhibitor pages | Primary source | No official current-year participant materials were supplied for validation | Pending verification |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to İstanbul Transcatheter Therapeutics Course (ITT) 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.